San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes ...

A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative ...

Delhi Assembly speaker Vijender Gupta called a meeting on Friday in Vidhan Sabha, during which committees formed to examine ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.